Journal
ONCOTARGET
Volume 7, Issue 25, Pages 38959-38972Publisher
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.8341
Keywords
metabolic syndrome; cancer risk; visceral adiposity; hyperglycemia; inflammation
Categories
Funding
- Italian Ministry of Research (PRIN grant)
- RSA
- University of Marche
Ask authors/readers for more resources
Metabolic syndrome is a cluster of risk factors that lead to cardiovascular morbidity and mortality. Recent studies linked metabolic syndrome and several types of cancer. Although metabolic syndrome may not necessarily cause cancer, it is linked to poorer cancer outcomes including increased risk of recurrence and overall mortality. This review tends to discuss the major biological and physiological alterations involved in the increase of incidence and mortality of cancer patients affected by metabolic syndrome. We focus on metabolic syndrome-associated visceral adiposity, hyperinsulinemia, hyperglycemia, insulin-like growth factor (IGF-I) pathway as well as estrogen signaling and inflammation. Several of these factors are also involved in carcinogenesis and cancer progression. A better understanding of the link between metabolic syndrome and cancer may provide new insight about oncogenesis. Moreover, prevention of metabolic syndrome-related alterations may be an important aspect in the management of cancer patients during simultaneous palliative care.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available